What is Xilio Therapeutics, Inc. Common Stock's Market Cap?

Xilio Therapeutics, Inc. Common Stock's Market Cap is $60.0M, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's Price / Sales?

Xilio Therapeutics, Inc. Common Stock's Price / Sales is 0.9×, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's Revenue (TTM)?

Xilio Therapeutics, Inc. Common Stock's Revenue (TTM) is $64.1M, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's Net Income (TTM)?

Xilio Therapeutics, Inc. Common Stock's Net Income (TTM) is -$21.8M, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's EBITDA?

Xilio Therapeutics, Inc. Common Stock's EBITDA is -$30.0M, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Xilio Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.32, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's EBITDA Margin?

Xilio Therapeutics, Inc. Common Stock's EBITDA Margin is -46.9%, based on as-reported figures from SEC (XBRL) filings.

Xilio Therapeutics, Inc. Common Stock (XLO) Financial Statements

Xilio Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00M4D4XC8

XNAS · usd

9.12▲ 0.21 (2.36%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close8.91

Day's Range8.81 – 9.11

52-Week Range0.46 – 9.90

Volume9,991

Avg Volume12.8K

Share Statistics

Shares Outstanding

Employees76

ExchangeXNAS

Listed2021-10-22

Share count as of June 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Xilio Therapeutics, Inc. Common Stock (XLO)

What is Xilio Therapeutics, Inc. Common Stock's Market Cap?: Xilio Therapeutics, Inc. Common Stock's Market Cap is $60.0M, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's Price / Sales?: Xilio Therapeutics, Inc. Common Stock's Price / Sales is 0.9×, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's Revenue (TTM)?: Xilio Therapeutics, Inc. Common Stock's Revenue (TTM) is $64.1M, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's Net Income (TTM)?: Xilio Therapeutics, Inc. Common Stock's Net Income (TTM) is -$21.8M, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's EBITDA?: Xilio Therapeutics, Inc. Common Stock's EBITDA is -$30.0M, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Xilio Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.32, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's EBITDA Margin?: Xilio Therapeutics, Inc. Common Stock's EBITDA Margin is -46.9%, based on as-reported figures from SEC (XBRL) filings.